201 related articles for article (PubMed ID: 18047657)
1. Metabolic signature of breast cancer cell line MCF-7: profiling of modified nucleosides via LC-IT MS coupling.
Bullinger D; Neubauer H; Fehm T; Laufer S; Gleiter CH; Kammerer B
BMC Biochem; 2007 Nov; 8():25. PubMed ID: 18047657
[TBL] [Abstract][Full Text] [Related]
2. Identification of urinary modified nucleosides and ribosylated metabolites in humans via combined ESI-FTICR MS and ESI-IT MS analysis.
Bullinger D; Fux R; Nicholson G; Plontke S; Belka C; Laufer S; Gleiter CH; Kammerer B
J Am Soc Mass Spectrom; 2008 Oct; 19(10):1500-13. PubMed ID: 18657436
[TBL] [Abstract][Full Text] [Related]
3. Exometabolom analysis of breast cancer cell lines: Metabolic signature.
Willmann L; Erbes T; Halbach S; Brummer T; Jäger M; Hirschfeld M; Fehm T; Neubauer H; Stickeler E; Kammerer B
Sci Rep; 2015 Aug; 5():13374. PubMed ID: 26293811
[TBL] [Abstract][Full Text] [Related]
4. Profiling of cis-diol-containing nucleosides and ribosylated metabolites by boronate-affinity organic-silica hybrid monolithic capillary liquid chromatography/mass spectrometry.
Jiang HP; Qi CB; Chu JM; Yuan BF; Feng YQ
Sci Rep; 2015 Jan; 5():7785. PubMed ID: 25585609
[TBL] [Abstract][Full Text] [Related]
5. The need for vigilance: false-negative screening for adenylosuccinate lyase deficiency caused by deribosylation of urinary biomarkers.
Krijt J; Skopova V; Adamkova V; Cermakova R; Jurecka A; Kmoch S; Zikanova M
Clin Biochem; 2013 Dec; 46(18):1899-901. PubMed ID: 24183879
[TBL] [Abstract][Full Text] [Related]
6. Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling.
Kammerer B; Frickenschmidt A; Müller CE; Laufer S; Gleiter CH; Liebich H
Anal Bioanal Chem; 2005 Jun; 382(4):1017-26. PubMed ID: 15906010
[TBL] [Abstract][Full Text] [Related]
7. Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients.
Frickenschmidt A; Frohlich H; Bullinger D; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Biomarkers; 2008 Jun; 13(4):435-49. PubMed ID: 18484357
[TBL] [Abstract][Full Text] [Related]
8. Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism.
Willmann L; Erbes T; Krieger S; Trafkowski J; Rodamer M; Kammerer B
Anal Bioanal Chem; 2015 May; 407(13):3555-66. PubMed ID: 25736241
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive profiling of ribonucleosides modification by affinity zirconium oxide-silica composite monolithic column online solid-phase microextraction - Mass spectrometry analysis.
Jiang HP; Chu JM; Lan MD; Liu P; Yang N; Zheng F; Yuan BF; Feng YQ
J Chromatogr A; 2016 Sep; 1462():90-9. PubMed ID: 27495369
[TBL] [Abstract][Full Text] [Related]
10. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells.
Sabina RL; Patterson D; Holmes EW
J Biol Chem; 1985 May; 260(10):6107-14. PubMed ID: 3997815
[TBL] [Abstract][Full Text] [Related]
11. Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selection.
Henneges C; Bullinger D; Fux R; Friese N; Seeger H; Neubauer H; Laufer S; Gleiter CH; Schwab M; Zell A; Kammerer B
BMC Cancer; 2009 Apr; 9():104. PubMed ID: 19344524
[TBL] [Abstract][Full Text] [Related]
12. BH
Lu Z; Liu X; Li X; Zhai C; Shi Y; Gao X
J Pharm Biomed Anal; 2022 Feb; 210():114555. PubMed ID: 34974239
[TBL] [Abstract][Full Text] [Related]
13. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of 5-amino-1-beta-D-ribofuranosylimidazole-4-carboxamide and related five-membered heterocycles to 5'-triphosphates in human blood and L5178Y cells.
Zimmerman TP; Deeprose RD
Biochem Pharmacol; 1978 Mar; 27(5):709-16. PubMed ID: 207278
[No Abstract] [Full Text] [Related]
16. Differentiation of 2'-O- and 3'-O-methylated ribonucleosides by tandem mass spectrometry.
Zhang Q; Wang Y
J Am Soc Mass Spectrom; 2006 Aug; 17(8):1096-1099. PubMed ID: 16750383
[TBL] [Abstract][Full Text] [Related]
17. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
18. Screening for adenylosuccinate lyase deficiency using tandem mass spectrometry analysis of succinylpurines in neonatal dried blood spots.
Zikanova M; Krijt J; Skopova V; Krijt M; Baresova V; Kmoch S
Clin Biochem; 2015 Jan; 48(1-2):2-7. PubMed ID: 25445730
[TBL] [Abstract][Full Text] [Related]
19. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
[TBL] [Abstract][Full Text] [Related]
20. Redox ribonucleosides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA.
Yanagawa H; Ogawa Y; Ueno M
J Biol Chem; 1992 Jul; 267(19):13320-6. PubMed ID: 1618833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
